Contract Manufacturing Organization (CMO) is a company that manufactures medical devices, components, or subassemblies to another firm’s specifications under contract. The client, usually the legal manufacturer or specification developer, owns the design and regulatory approvals, while the CMO runs production under a shared quality system and supply agreement.
What is a Contract Manufacturing Organization (CMO)?
A Contract Manufacturing Organization (CMO) makes finished devices or parts for a company that holds the product’s design, brand, and market authorization. In the device industry, the client is often called the legal manufacturer under EU MDR or the specification developer under FDA rules, and the CMO is the establishment that physically builds the product.
A CMO handles production only. When a partner also provides design and development, engineering, and regulatory support, it is usually called a CDMO (Contract Development and Manufacturing Organization). The distinction matters for how responsibility is split, since design controls and manufacturing controls then sit with different owners.
Why a Contract Manufacturing Organization (CMO) matters in medical device development
Outsourcing production does not outsource accountability. Under FDA rules, contract manufacturers of finished devices must register their establishment and list the device, and they operate under the Quality Management System Regulation (QMSR, 21 CFR Part 820), which, since February 2, 2026, incorporates ISO 13485:2016 by reference. The specification developer still carries ultimate responsibility for final device quality.
The stakes are concrete. A weak CMO relationship shows up as nonconformances, field failures, recalls, and warning letters. It also shows up on the calendar: a poorly managed design transfer or an unqualified process can delay a launch by months. Because a notified body or an FDA investigator can inspect the CMO’s records directly, both parties are exposed to the same findings.
How a Contract Manufacturing Organization (CMO) works
The relationship runs on documented controls, not trust. Its core elements:
- Quality agreement. A written contract defining who owns each activity: incoming inspection, process validation, change control, complaint data, and product release. ISO 13485 Clause 4.1.5 requires the client to control outsourced processes, and the quality agreement is how that control is evidenced.
- Design transfer. The client’s design outputs (drawings, specifications, BOM, test methods) move into the CMO’s production environment and are proven manufacturable at scale.
- Process validation. IQ, OQ, and PQ demonstrate that equipment and processes reliably produce conforming products, supported by PFMEA and linked to the risk file under ISO 14971:2019.
- Supplier qualification. The legal manufacturer audits and approves the CMO, then monitors performance through metrics and periodic re-audits.
- Traceability and change control. Lot records, device history records, and a shared change-control path keep both quality systems aligned and revalidation predictable.
Which standards apply depends on the device. IEC 60601-1 governs electrical safety for active devices, IEC 62304 covers the device software lifecycle, and ISO 11607 covers sterile barrier packaging. For companies selling across regions, a single MDSAP audit can satisfy several regulators at once.
Common challenges and best practices
The most frequent failure is an unclear split of responsibility. When the quality agreement is vague, complaints, CAPAs, and change requests fall through the gap between the two quality systems. Write it in detail before the first production run, and revisit it whenever the process changes.
Change control is the second recurring problem. A CMO that alters a supplier, a resin grade, or a process parameter without telling the client can invalidate a validation and, in the worst case, the device’s regulatory status. Good practice ties every proposed change to an impact assessment and a defined approval route.
Communication gaps make both issues worse. Teams that treat the CMO as an arm’s-length vendor, rather than an integrated partner with shared metrics and regular reviews, tend to find problems during an audit instead of before one.
How SJML helps with a Contract Manufacturing Organization (CMO)
Syrma Johari MedTech (SJML) is an end-to-end medical device CDMO, combining design, engineering, manufacturing, and regulatory compliance under one roof. On the production side, SJML runs ISO Class 7 and 8 cleanrooms and ESD-controlled lines for medical PCBA, plastics, precision metal, cable harnesses, and box build, with process validation (IQ/OQ/PQ), PFMEA, and SAP-integrated traceability. The QARA team supports device classification, technical files, and QMS work aligned to ISO 13485, FDA 21 CFR Part 820, and EU MDR/IVDR, so production and compliance advance together across Class I, II, and III devices.
Talk to SJML’s manufacturing team →
Frequently asked questions
A CMO (Contract Manufacturing Organization) provides manufacturing only, building a device to the specifications the client already owns. A CDMO (Contract Development and Manufacturing Organization) adds design, engineering, and often regulatory support, so it can take a product from concept through production. The choice depends on whether the client needs a builder or a full development partner.
The legal manufacturer or specification developer holds ultimate responsibility for the device, including its market authorization and final quality. The CMO must still comply with applicable quality system rules, register its establishment with the FDA, and follow the quality agreement. Both parties can be inspected, so the responsibilities are shared but not equal.
ISO 13485:2016 certification is not always a legal requirement, but it is the practical baseline for device CMOs. Since the FDA’s QMSR incorporates ISO 13485 by reference as of February 2026, and EU MDR relies on it as a harmonized standard, most legal manufacturers require their CMO to hold current certification before awarding work.
A quality agreement is a written document that defines quality roles and responsibilities between the client and the CMO. It covers incoming inspection, process validation, change control, complaint handling, and product release. It gives both quality systems a single reference point and is one of the first documents a notified body or FDA investigator will ask to see.
Related terms
- Contract Development and Manufacturing Organization (CDMO)
- Design Transfer
- Process Validation (IQ/OQ/PQ)
- Supplier Qualification
- Quality Agreement
